Armata Pharmaceuticals (ARMP) Share-based Compensation: 2013-2024
Historic Share-based Compensation for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to $2.9 million.
- Armata Pharmaceuticals' Share-based Compensation fell 100.76% to -$1,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $142,000, marking a year-over-year decrease of 79.71%. This contributed to the annual value of $2.9 million for FY2024, which is 208.42% up from last year.
- Latest data reveals that Armata Pharmaceuticals reported Share-based Compensation of $2.9 million as of FY2024, which was up 208.42% from $938,000 recorded in FY2023.
- Over the past 5 years, Armata Pharmaceuticals' Share-based Compensation peaked at $3.5 million during FY2020, and registered a low of $938,000 during FY2023.
- In the last 3 years, Armata Pharmaceuticals' Share-based Compensation had a median value of $2.9 million in 2024 and averaged $2.3 million.
- In the last 5 years, Armata Pharmaceuticals' Share-based Compensation tumbled by 69.79% in 2023 and then surged by 208.42% in 2024.
- Armata Pharmaceuticals' Share-based Compensation (Yearly) stood at $3.5 million in 2020, then decreased by 17.06% to $2.9 million in 2021, then rose by 7.74% to $3.1 million in 2022, then plummeted by 69.79% to $938,000 in 2023, then skyrocketed by 208.42% to $2.9 million in 2024.